Robeco Schweiz Ag Gilead Sciences, Inc. Transaction History

Robeco Schweiz Ag

$4.84 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $8.33 Million - $9.5 Million	-138,769 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $3.87 Million - $4.41 Million	-68,251 Reduced 32.97%	138,769 $8.09 Million
Q3 2020 Oct 13, 2020	SELL	$62.1 - $78.08 $80,730 - $101,504	-1,300 Reduced 0.62%	207,020 $13.1 Million
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $4.53 Million - $5.27 Million	-62,689 Reduced 23.13%	208,320 $16 Million
Q1 2020 Apr 10, 2020	BUY	$62.63 - $80.22 $1.36 Million - $1.74 Million	21,660 Added 8.69%	271,009 $20.6 Million
Q4 2019 Feb 13, 2020	BUY	$61.62 - $67.78 $183,627 - $201,984	2,980 Added 1.21%	249,349 $65,000
Q3 2019 Oct 18, 2019	BUY	$62.51 - $69.0 $718,177 - $792,741	11,489 Added 4.89%	246,369 $15.5 Million
Q2 2019 Jul 31, 2019	BUY	$61.87 - $69.38 $2.19 Million - $2.45 Million	35,367 Added 17.73%	234,880 $15.8 Million
Q1 2019 May 14, 2019	BUY	$62.53 - $70.05 $327,657 - $367,062	5,240 Added 2.7%	199,513 $13 Million
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $297,372 - $388,048	4,912 Added 2.59%	194,273 $12 Million
Q3 2018 Oct 30, 2018	BUY	$71.28 - $78.92 $4.09 Million - $4.53 Million	57,427 Added 43.53%	189,361 $14.5 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $142,671 - $166,420	2,199 Added 1.69%	131,934 $9.28 Million
Q1 2018 May 16, 2018	SELL	$72.84 - $88.8 $60,821 - $74,148	-835 Reduced 0.64%	129,735 $9.78 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $41,551 - $48,775	-584 Reduced 0.45%	130,570 $9.46 Million
Q3 2017 Nov 09, 2017	SELL	$72.11 - $85.47 $1.84 Million - $2.18 Million	-25,455 Reduced 16.25%	131,154 $10.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	156,609	156,609 $11.1 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$10.9 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.4 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$6.9 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.57 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.43 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Schweiz Ag, based on Form 13F filings with the SEC.

News

Stay updated on Robeco Schweiz Ag with notifications on news.

Account